News

THIRUVANANTHAPURAM: The Association of Medical and Paediatric Oncologists of Kerala (AMPOK) announced a research grant of Rs ...
Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...
Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...
BEYONTTRA is an orally administered near-complete (≥90%) stabilizer of transthyretin (TTR) indicated for the treatment of wild-type or variant transthyretin amyloidosis in adult patients with ...
Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people worldwide. Synapses are ...
Harry Monroe has been an educator for 51 years. He spent 33 of those with Dallas ISD. Now, he's leaving for health reasons.
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled ...
Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.
Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...
CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...